eMJA     The Medical Journal of Australia

Home | Issues | eMJA shop | My account | Classifieds | Contact | More... | Topics | Search   

Letters

Fatal leptospirosis presenting as musculoskeletal pain

MJA 2004; 181 (4): 229

Lloyd K Morgan

General practitioner (retired), PO Box 150, Lorne, VIC 3232. lloydmorganATiprimus.com.au

To the Editor: O’Leary et al1 are pessimistic about the value of antibiotic treatment for leptospirosis, based on an inconclusive Cochrane review2 and no proven mortality decrease. Yet we can be more optimistic, given the efficacy of prophylactic doxycycline (soldiers in Panama were 95% protected by 200 mg once-weekly3), the susceptibility of leptospira to various antibiotics in vitro (especially penicillin, but not erythromycin4), and the existence of a Herxheimer reaction with penicillin,5 which indicates in-vivo activity.

The Cochrane review2 was of randomised controlled trials of confirmed cases. It included 75 patients given antibiotics and 75 given placebo. Penicillin (61 patients) and doxycycline were not compared. The time from symptom onset to starting antibiotics was stated in only two trials (9 and 2 days). Nevertheless, the review concluded that penicillin or doxycycline may do more good than harm.

In the spirochetaemic phase of leptospirosis (Days 4–7), vasculitis causes multiorgan failure. Successful treatment with antibiotics seems likely if commenced within 2 days of symptom onset, before generalised vasculitis is irreversible. Unfortunately, early diagnosis and efficacy assessment is difficult because symptoms are protean and non-specific, no rapid laboratory test exists, the condition is mild and self-limited in most cases, and mortality varies from zero to 7%. A high index of suspicion is essential so that antibiotics can be commenced empirically.

The consensus is that antibiotics should be commenced within 4 days. In one study, starting antibiotics within 7 days was associated with shorter illness, and if antibiotics were started within 2 days the shorter duration was highly significant (P = 0.006).6 Another trial showed penicillin commenced on Day 9 was beneficial, but antibiotics had been used before entry to the trial.2

Various penicillins and tetracyclines have seemed useful, but only oral doxycycline and intravenous benzylpenicillin are recommended. These are the first and second preferences, respectively, in Therapeutic guidelines antibiotic.7

In the case described by O’Leary et al,1 antibiotics were commenced on Day 3, but the penicillin dose was only half the recommended daily dose for leptospirosis. The vasculitis was probably terminal before the patient was transferred to Concord Hospital.

  1. O’Leary F, Hanson J, Bradbury R, Thanakrishman G. Fatal leptospirosis presenting as musculoskeletal chest pain. Med J Aust 2004; 180: 29-31. <eMJA full text> <PubMed>
  2. Guidugli F, Castro AA, Atallah AN. Antibiotics for leptospirosis (Cochrane review). In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd.
  3. Takfuji E, Kirkpatrick J, Miller R, et al. An efficiency trial of doxycyline chemoprophylaxis against leptospirosis. N Engl J Med 1984; 310: 497-500. <PubMed>
  4. Kucers A, Crow S, Grayson M, Hoy J. The use of antibiotics: a clinical review of antibacterial, antifungal and antiviral drugs. 5th ed. Boston: Butterworth-Heinemann, 1997.
  5. Friedland J, Warral D. The Jarisch-Herxheimer reaction in leptospirosis: possible pathogenesis and review. Rev Infect Dis 1991; 13: 207-210. <PubMed>
  6. Katz A, Ansdell V, Effler P, et al. Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii 1974–1998. Clin Infect Dis 2001; 33: 1834-1841. <PubMed>
  7. Therapeutic guidelines. Antibiotic. Version 12. Melbourne: Therapeutic Guidelines, 2003.

©The Medical Journal of Australia 2004 www.mja.com.au ISSN: 0025-729X

Home | Issues | eMJA shop | My account | Classifieds | More... | Contact | Topics | Search

The Medical Journal of Australia    eMJA